The Future of Personalized Medicine: Cell and Gene Therapies at the Forefront
In recent years, medicine has begun shifting from generalized treatments toward a more personalized approach. It offers the potential to treat complex conditions with greater precision and effectiveness. Leading this shift are cell and gene therapies (CGT), which have emerged as pioneering technologies. Understanding Cell and Gene Therapies in Personalized Medicine Cell and gene therapies […]
Progress Highlights: Phase II/III Immunotherapy Trial for Advanced Liver Cancer
Introduction and Study Overview Clinixir, Thailand’s leading Contract Research Organization (CRO), is pleased to share progress on a Phase II/III clinical trial investigating a potential immunotherapy for advanced hepatocellular carcinoma. This randomized, controlled study aims to enroll 150 patients across sites in Thailand and Malaysia. Clinixir’s role has focused on activating sites, coordinating patient recruitment, […]
Global Insights: The Rapid Growth of Cell and Gene Therapy Clinical Trials in 2024
The field of cell and gene therapy is witnessing a profound and rapid expansion, with clinical trials globally marking a significant rise in 2024. Clinixir, dedicated to advancing clinical trials in Thailand and Southeast Asia, is at the forefront of understanding these developments. As we explore the trajectory of cell and gene therapy (CGT), we’ll […]
Key Considerations for Conducting Clinical Trials in Pediatrics
This article explores key considerations for conducting clinical trials in pediatrics, focusing on ethical issues, consent, safety, study design, and regulatory requirements.
Best Practices for Writing Informed Consent Forms in Clinical Research
A well-written ICF is a vital tool for establishing trust, protecting the rights of participants, and promoting transparency.
Decentralized Clinical Trials: Best Practices for Implementing Hybrid Models in 2024-2025
As the world of clinical research continues to evolve, decentralized clinical trials (DCTs) have become a focal point in the pharmaceutical industry, reshaping how studies are conducted. The years 2024 and 2025 are pivotal, marking a period where hybrid models of DCTs are being fine-tuned and widely adopted. These models blend traditional, centralized methods with […]
The Crucial Role of Non-Interventional Studies in Ensuring Drug Safety and Efficacy
Non-interventional studies (NIS), often referred to as observational studies, are essential in assessing the safety and efficacy of drugs outside the rigid and controlled environment of randomized controlled trials (RCTs). While RCTs are the gold standard for determining a drug’s initial safety and effectiveness, NIS plays a crucial role in providing a more comprehensive understanding […]
Understanding the Stages of Clinical Trials
Clinical research is an indispensable part of developing new medical treatments and understanding health and disease. The process is rigorous, structured, and divided into distinct stages and phases to maximize safety and efficacy.
Clinixir’s Commitment to ISO 9001: A Benchmark in Quality and Excellence
In the highly competitive landscape of clinical research, maintaining the highest standards of quality is not just a goal; it’s a necessity. At Clinixir, we understand the importance of delivering consistent, high-quality services to our clients and stakeholders. Our commitment to achieving and maintaining ISO 9001 certification is a testament to this dedication. Understanding ISO […]
The CRA’s Guide to Monitoring Clinical Research
Clinical Research Associates (CRAs) are integral to maintaining the integrity and compliance of clinical trials. They oversee every stage from study initiation through to closeout, ensuring adherence to regulatory standards and prioritizing participant safety.
